Cargando…

Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high‐grade serous ovarian cancer

Although the association between tumor‐infiltrating CD3(+) T and CD8(+) T cells and superior survival in high‐grade serous ovarian cancer (HGSOC) has been observed, the different spatial localization of tumor‐infiltrating lymphocytes (TILs) possesses heterogeneous effects. We performed localized mea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Guodong, Xu, Qing, Zhang, Xiangyun, Yang, Moran, Wang, Yiying, He, Mengdi, Lu, Jiaqi, Liu, Haiou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209602/ https://www.ncbi.nlm.nih.gov/pubmed/33955198 http://dx.doi.org/10.1002/cam4.3942

Ejemplares similares

Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response
por: Cao, Kankan, et al.
Publicado: (2021)

CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer
por: Yang, Moran, et al.
Publicado: (2021)

C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer
por: Zhang, Chen, et al.
Publicado: (2023)

Siglec-9(+) tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer
por: Wang, Yiying, et al.
Publicado: (2023)

The immune landscape during the tumorigenesis of cervical cancer
por: Wang, Yiying, et al.
Publicado: (2021)

Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer
por: Yang, Moran, et al.
Publicado: (2020)

High-grade serous ovarian carcinoma organoids as models of chromosomal instability
por: Vias, Maria, et al.
Publicado: (2023)

Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
por: Hanker, L. C., et al.
Publicado: (2021)

Spatially resolved transcriptomics of high-grade serous ovarian carcinoma
por: Stur, Elaine, et al.
Publicado: (2022)

The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
por: Cheng, Zhao, et al.
Publicado: (2022)

The prognostic significance of tumor-infiltrating lymphocytes in cervical cancer
por: He, Mengdi, et al.
Publicado: (2021)

Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario
por: McGee, Jacob, et al.
Publicado: (2017)

First-Line Management of Advanced High-Grade Serous Ovarian Cancer
por: Mahmood, Reem D., et al.
Publicado: (2020)

Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer
por: Xu, Junfen, et al.
Publicado: (2022)

Comprehensive genomic profiling of high‐grade serous ovarian carcinoma from Chinese patients identifies co‐occurring mutations in the Ras/Raf pathway with TP53
por: Zhong, Fangfang, et al.
Publicado: (2019)

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer
por: Song, Honglin, et al.
Publicado: (2021)

Cellular Senescence in the Treatment of Ovarian Cancer
por: Wang, Zehua, et al.
Publicado: (2018)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

CCNG1 (Cyclin G1) regulation by mutant‐P53 via induction of Notch3 expression promotes high‐grade serous ovarian cancer (HGSOC) tumorigenesis and progression
por: Xu, Ying, et al.
Publicado: (2018)

Protein anabolism is key to long-term survival in high-grade serous ovarian cancer
por: Wang, Lingxiang, et al.
Publicado: (2020)

Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
por: Schwarz, Roland F., et al.
Publicado: (2015)

Dualistic classification of high grade serous ovarian carcinoma has its root in spatial heterogeneity
por: Sun, Tingting, et al.
Publicado: (2022)

Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first‐line platinum chemotherapy in high grade serous ovarian cancer
por: Weberpals, Johanne I., et al.
Publicado: (2021)

Tubal Origin of “Ovarian” Low-Grade Serous Carcinoma: A Gene Expression Profile Study
por: Wang, Yiying, et al.
Publicado: (2019)

Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence
por: Tsonis, Orestis, et al.
Publicado: (2020)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

The transcriptomic profile of ovarian cancer grading
por: Yao, Cindy Q, et al.
Publicado: (2015)

Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
por: Yang, Bin, et al.
Publicado: (2022)

Phenethyl Isothiocyanate Enhances the Cytotoxic Effects of PARP Inhibitors in High-Grade Serous Ovarian Cancer Cells
por: Jia, Yaxun, et al.
Publicado: (2022)

Survival of Advanced Stage High-Grade Serous Ovarian Cancer Patients in the Republic of Macedonia
por: Aluloski, Igor, et al.
Publicado: (2017)

Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival
por: Carlson, Joseph W., et al.
Publicado: (2018)

Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers
por: Bischof, Katharina, et al.
Publicado: (2019)

Outcome in serous ovarian cancer is not associated with LATS expression
por: Montavon, Céline, et al.
Publicado: (2019)

A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology
por: Chen, Ming, et al.
Publicado: (2014)

Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival
por: Lisowska, Katarzyna M., et al.
Publicado: (2016)

High expression of sperm-associated antigen 5 correlates with poor survival in ovarian cancer
por: Zhang, Mei, et al.
Publicado: (2020)

Development of survival predictors for high-grade serous ovarian cancer based on stable radiomic features from computed tomography images
por: Hu, Jiaqi, et al.
Publicado: (2022)

Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer
por: Xie, Hongyu, et al.
Publicado: (2017)

NKG2D‐mediated cytotoxicity improves after primary surgery for high‐grade serous ovarian cancer
por: Israelsson, Pernilla, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hfhkpfjvsasppg3i6aujue3hv5